326 related articles for article (PubMed ID: 34331569)
41. Merkel cell carcinomas infiltrated with CD33
Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
[TBL] [Abstract][Full Text] [Related]
42. The expression of terminal deoxynucleotidyl transferase and paired box gene 5 in Merkel cell carcinomas and its relation to the presence of Merkel cell polyomavirus DNA.
Johansson B; Sahi H; Koljonen V; Böhling T
J Cutan Pathol; 2019 Jan; 46(1):26-32. PubMed ID: 30315594
[TBL] [Abstract][Full Text] [Related]
43. Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-ERK pathway activation.
Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Kohashi K; Kuwamoto S; Umekita Y; Oda Y
Cancer Sci; 2022 Jan; 113(1):251-260. PubMed ID: 34724284
[TBL] [Abstract][Full Text] [Related]
44. Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.
van Veenendaal LM; van Akkooi ACJ; Verhoef C; Grünhagen DJ; Klop WMC; Valk GD; Tesselaar MET
J Surg Oncol; 2018 Jun; 117(8):1768-1775. PubMed ID: 29790179
[TBL] [Abstract][Full Text] [Related]
45. Merkel cell carcinoma update: the case for two tumours.
Nirenberg A; Steinman H; Dixon J; Dixon A
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1425-1431. PubMed ID: 31855292
[TBL] [Abstract][Full Text] [Related]
46. Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.
Iwasaki T; Matsushita M; Nonaka D; Kato M; Nagata K; Murakami I; Hayashi K
Pathol Int; 2015 Aug; 65(8):404-9. PubMed ID: 25982855
[TBL] [Abstract][Full Text] [Related]
47. Detection of Merkel cell polyomavirus (MCPyV) in Merkel cell carcinoma cell lines: cell morphology and growth phenotype do not reflect presence of the virus.
Fischer N; Brandner J; Fuchs F; Moll I; Grundhoff A
Int J Cancer; 2010 May; 126(9):2133-42. PubMed ID: 19739110
[TBL] [Abstract][Full Text] [Related]
48. [Merkel cell carcinoma].
Fried I; Cerroni L
Pathologe; 2014 Sep; 35(5):467-75. PubMed ID: 25074367
[TBL] [Abstract][Full Text] [Related]
49. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma.
Henderson SA; Tetzlaff MT; Pattanaprichakul P; Fox P; Torres-Cabala CA; Bassett RL; Prieto VG; Richards HW; Curry JL
J Cutan Pathol; 2014 Nov; 41(11):846-52. PubMed ID: 25263506
[TBL] [Abstract][Full Text] [Related]
50. Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma.
Gujar H; Mehta A; Li HT; Tsai YC; Qiu X; Weisenberger DJ; Jasiulionis MG; In GK; Liang G
Genome Med; 2021 Aug; 13(1):130. PubMed ID: 34399838
[TBL] [Abstract][Full Text] [Related]
51. Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma.
Blom A; Bhatia S; Pietromonaco S; Koehler K; Iyer JG; Nagase K; Paulson K; Sabath DE; Nghiem P
J Am Acad Dermatol; 2014 Mar; 70(3):449-55. PubMed ID: 24388423
[TBL] [Abstract][Full Text] [Related]
52. Intraepidermal Merkel cell carcinoma with no dermal involvement.
Brown HA; Sawyer DM; Woo T
Am J Dermatopathol; 2000 Feb; 22(1):65-9. PubMed ID: 10698220
[TBL] [Abstract][Full Text] [Related]
53. Merkel cell carcinoma: Do you know your guidelines?
Miles BA; Goldenberg D;
Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756
[TBL] [Abstract][Full Text] [Related]
54. Merkel cell carcinoma: clinical characteristics, markers, staging and treatment.
Lien MH; Baldwin BT; Thareja SK; Fenske NA
J Drugs Dermatol; 2010 Jul; 9(7):779-84. PubMed ID: 20677532
[TBL] [Abstract][Full Text] [Related]
55. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
Walsh NM; Fleming KE; Hanly JG; Dakin Hache K; Doucette S; Ferrara G; Cerroni L
Hum Pathol; 2016 Jun; 52():190-6. PubMed ID: 26980039
[TBL] [Abstract][Full Text] [Related]
56. Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).
Suárez AL; Louis P; Kitts J; Busam K; Myskowski PL; Wong RJ; Chen CS; Spencer P; Lacouture M; Pulitzer MP
J Am Acad Dermatol; 2015 Dec; 73(6):968-75. PubMed ID: 26433246
[TBL] [Abstract][Full Text] [Related]
57. Relationship between p63 and p53 expression in Merkel cell carcinoma and corresponding abnormalities in TP63 and TP53: a study and a proposal.
DeCoste RC; Carter MD; Pasternak S; Fleming KE; Gaston D; Legge A; Ly TY; Walsh NM
Hum Pathol; 2021 Nov; 117():31-41. PubMed ID: 34391748
[TBL] [Abstract][Full Text] [Related]
58. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
Pulitzer MP; Brannon AR; Berger MF; Louis P; Scott SN; Jungbluth AA; Coit DG; Brownell I; Busam KJ
Mod Pathol; 2015 Aug; 28(8):1023-32. PubMed ID: 26022453
[TBL] [Abstract][Full Text] [Related]
60. Intraepidermal Merkel Cell Carcinoma Mimicking Melanoma in Situ: A Case Report.
Song Y; Zheng S; Guo Y
Am J Dermatopathol; 2020 Dec; 42(12):977-980. PubMed ID: 32956096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
